Cargando…

Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens

BACKGROUND: Hepatitis C virus (HCV) is a risk factor for chronic kidney disease (CKD) and end-stage renal disease (ESRD). Direct-acting antiviral agents (DAAs) have improved HCV management in CKD patients, however real-world clinical practice data are limited. OBJECTIVE: This study examined the prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puenpatom, Amy, Hull, Michael, McPheeters, Jeffrey, Schwebke, Kay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488145/ https://www.ncbi.nlm.nih.gov/pubmed/28386819 http://dx.doi.org/10.1007/s40261-017-0526-z

Ejemplares similares

Treatment Discontinuation, Adherence, and Real-World Effectiveness Among Patients Treated with Ledipasvir/Sofosbuvir in the United States
por: Puenpatom, Amy, et al.
Publicado: (2017)

Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong
por: Yuen, Man-Fung, et al.
Publicado: (2020)

Healthcare utilization and costs among patients with herpes zoster and solid tumor malignancy on chemotherapy: A retrospective cohort study
por: Mao, Jianbin, et al.
Publicado: (2017)

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy
por: Bengtson, Lindsay G.S., et al.
Publicado: (2018)

Interferon-Free Regimens and Direct-Acting Antiviral Agents for Delta Hepatitis: Are We There Yet?
por: Nemteanu, Roxana, et al.
Publicado: (2023)

Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon
por: Mascia, Claudia, et al.
Publicado: (2017)

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
por: Lee, Hye Won, et al.
Publicado: (2020)

Counter-Point: Frequent Users of the Emergency Department: Meeting Society’s Needs
por: McPheeters, Rick A.
Publicado: (2009)

Lying-In Hospital, Dublin, October 11th, 1858
por: McPheeters, W. A.
Publicado: (1859)

Plagues, Public Health, and Politics
por: Koplan, Jeffrey P., et al.
Publicado: (2004)

The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries
por: Mennini, Francesco S., et al.
Publicado: (2021)

Reentrant Supraventricular Tachycardia in a Pediatric Trauma Patient Masquerading as a Cardiac Contusion
por: Bradbum, Christopher, et al.
Publicado: (2005)

Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
por: Tronina, Olga, et al.
Publicado: (2023)

Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis
por: Kwo, Paul Y., et al.
Publicado: (2019)

Chemical Pneumonitis from Hydrocarbon Aspiration
por: Pham, Keimanh, et al.
Publicado: (2008)

Raccoon Eyes
por: McPheeters, Rick A., et al.
Publicado: (2010)

Hydrocele of the Canal of Nuck
por: Heer, Jagdipak, et al.
Publicado: (2015)

Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
por: Lima, Viviane D., et al.
Publicado: (2015)

Cervical Ectopic Pregnancy
por: Heer, Jag S, et al.
Publicado: (2012)

Spontaneous frontal intradiploic meningoencephalocele
por: McPheeters, Matthew James, et al.
Publicado: (2015)

Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016–2021
por: Carson, Joanne, et al.
Publicado: (2023)

Adaptation of Predictive Models to PDA Hand-Held Devices
por: Lin, Edward J., et al.
Publicado: (2008)

Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States
por: Rosenthal, Elana S., et al.
Publicado: (2016)

Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus
por: Franco, Evelyn J., et al.
Publicado: (2021)

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon
por: Gambato, Martina, et al.
Publicado: (2016)

Improvement of performance of InAs quantum dot solar cell by inserting thin AlAs layers
por: Hu, Dongzhi, et al.
Publicado: (2011)

Record Linkage Approaches Using Prescription Drug Monitoring Program and Mortality Data for Public Health Analyses and Epidemiologic Studies
por: Nechuta, Sarah, et al.
Publicado: (2020)

Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals
por: Alexopoulou, Alexandra, et al.
Publicado: (2015)

Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
por: Salama, Iman Ibrahim, et al.
Publicado: (2022)

Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon
por: Gambato, Martina, et al.
Publicado: (2017)

Transparency and Trust During the Coronavirus Disease 2019 (COVID-19) Pandemic
por: Spalluto, Lucy B., et al.
Publicado: (2020)

Fatal Pulmonary Embolism in a 10-Year Old With Nephrotic Syndrome
por: McPheeters, Rick A., et al.
Publicado: (2003)

This article corrects: “Hydrocele of the Canal of Nuck”
por: Heer, Jagdipak, et al.
Publicado: (2015)

Prevalence and Risk Factors Associated With Long-term Opioid Use After Injury Among Previously Opioid-Free Workers
por: Durand, Zoe, et al.
Publicado: (2019)

Diagnostic testing managed by hematopathology specialty and other laboratories: costs and patient diagnostic outcomes
por: Engel-Nitz, Nicole M, et al.
Publicado: (2014)

Antiviral activities of interferons
por: Stewart, William E., et al.
Publicado: (1979)

Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C
por: Ramamurthy, Narayan, et al.
Publicado: (2018)

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease
por: Chang, Christine Y., et al.
Publicado: (2017)

Statin discontinuation in persons with and without Alzheimer’s disease
por: Vu, Mai, et al.
Publicado: (2022)

Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents
por: Kamal, Sanaa M
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7rsibo8aa82ccs1k131o3h8aqb